Skip to main content
. Author manuscript; available in PMC: 2024 Jun 26.
Published in final edited form as: Ophthalmic Epidemiol. 2021 Feb 21;28(6):533–539. doi: 10.1080/09286586.2021.1883675

Table 5.

Payments per covered year for SD vs. AMD

Variables Coefficient (95% CI) P-value
Condition
 SD* Reference
 AMD − 17.34 (− 22.47, − 12.22) <0.001
Age 1.58 (1.42, 1.74) <0.001
Sex
 Male Reference
 Female 3.04 (1.71, 4.37) <0.001
Year service was rendered
 2010 Reference
 2011 − 38.51 (− 40.44, − 36.59) <0.001
 2012 − 48.74 (− 50.72, − 46.76) <0.001
 2013 − 47.71 (− 49.73, − 45.70) <0.001
 2014 − 51.59 (− 53.62, − 49.55) <0.001
Type of benefit plan
 PPO Reference
 Comprehensive − 14.79 (− 18.14, − 11.44) <0.001
 EPO 1.97 (− 2.21, 6.14) 0.356
 HMO − 4.79 (− 7.10, − 2.48) <0.001
 POS − 0.70 (− 3.11, 1.72) 0.571
 POS with capitation 9.84 (1.92, 17.76) 0.015
 CDHP − 8.80 (− 11.97, − 5.62) <0.001
 HDHP 1.97 (− 1.83, 5.78) 0.309
*

SD patients aged ≥50 years, CI: confidence interval, SD: stargardt disease, AMD: non-exudative age related macular degeneration, PPO: preferred provider organization, EPO: exclusive provider organization, HMO: health maintenance organization, POS: point-of-service, CDHP: consumer directed health plan, HDHP: high deductible health plan